Larvol Delta - New-analyses-of-data-from-RewinDLB-Trial-stratified-by-plasma-pTau181-subset-demonstrate-greater-treatment-effect-with-reduced-likelihood-of-AD-copathology

neflamapimod (VX-745) - CervoMed

https://www.globenewswire.com/news-release/2026/03/19/3258892/0/en/cervomed-announces-new-data-at-the-ad-pd-2026-scientific-conference-that-reinforce-neflamapimod-s-positive-effects-in-dementia-with-lewy-bodies-dlb-in-patients-without-alzheimer-s-.html

Mar 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next